Jafron Biomedical Co Ltd
SZSE:300529
Wall Street
Price Targets
Price Targets Summary
Jafron Biomedical Co Ltd
According to Wall Street analysts, the average 1-year price target for Jafron Biomedical Co Ltd is 29.79 CNY with a low forecast of 29.5 CNY and a high forecast of 30.67 CNY.
Operating Income
Forecast
Operating Income Estimate
Jafron Biomedical Co Ltd
For the last 8 years the compound annual growth rate for Jafron Biomedical Co Ltd's operating income is 11%. The projected CAGR for the next 3 years is 58%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Jafron Biomedical Co Ltd's stock price target?
Price Target
29.79
CNY
According to Wall Street analysts, the average 1-year price target for Jafron Biomedical Co Ltd is 29.79 CNY with a low forecast of 29.5 CNY and a high forecast of 30.67 CNY.
What is Jafron Biomedical Co Ltd's Revenue forecast?
Projected CAGR
20%
For the last 8 years the compound annual growth rate for Jafron Biomedical Co Ltd's revenue is 18%. The projected CAGR for the next 4 years is 20%.
What is Jafron Biomedical Co Ltd's Operating Income forecast?
Projected CAGR
58%
For the last 8 years the compound annual growth rate for Jafron Biomedical Co Ltd's operating income is 11%. The projected CAGR for the next 3 years is 58%.
What is Jafron Biomedical Co Ltd's Net Income forecast?
Projected CAGR
32%
For the last 8 years the compound annual growth rate for Jafron Biomedical Co Ltd's net income is 10%. The projected CAGR for the next 4 years is 32%.
You don't have any saved screeners yet
